Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01513031 · ClinicalTrials.gov registry record · Phase 4
Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation
A Phase 4 study, sponsored by Creighton University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT01513031: Clinical Trial Phase 4 study, sponsored by Creighton University.
NCT01513031 is a Phase 4 study that was terminated before completion, run by Creighton University. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01513031, a Phase 4 study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.
Primary Outcome
Assessing whether patients stop taking anti-arrhythmic medication without instruction to do so by their physician.
Interventions
- OTHER Education and telephone follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Why NCT01513031 stopped before completion
NCT01513031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Education and telephone follow-up is the first listed.
NCT01513031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01513031 about?
NCT01513031 is a clinical study titled "Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation". The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti...
What is the current status of trial NCT01513031?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01513031?
The interventions under investigation include: Education and telephone follow-up (OTHER).
Who is sponsoring clinical trial NCT01513031?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01513031's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia